Rite Aid's Sell-off Was Pointless, but Not a Reason to Buy

Drugstore chain Rite Aid (NYSE: RAD  ) was clobbered in Thursday's trading after the company reported that fiscal 2015 sales would be hindered by rising drug costs and that guidance was coming down by $0.02 on the top end and $0.01 on the bottom line. In isolation, the market reaction looks like a typical overreaction, and indicates that long-term investors could get in on the stock at a discounted price. Rite Aid has been in turnaround mode for the past couple of years, and the stock has skyrocketed well beyond its dirt cheap valuation in 2012. Does this week's discount give bargain-hunting investors another shot at the stock?

Short story
As an investor in Rite Aid stock, the fact that full-year earnings may come in a bit lower than previously expected is perhaps frustrating, especially if one recently bought the high-flying security. On the other hand, if one views themselves as a long-term part-owner of Rite Aid's business, the fact that drug prices will keep pressure on margins in the near term is of little to no concern for the ultimate success of the company.

The news simply does not affect the long-term value of the company, and says nothing about the operating business. Whether that implies that the shares are on sale is a different story.

A buy?
Rite Aid's return to the good graces of the market is a product of a few trends, mainly the recovery in the company's margins. With such slim operating and profit margins, Rite Aid can make tiny, incremental improvements in its pharmacy and front-of-store business and achieve tremendous gains on the bottom line of its income statement. Over the past several quarters, this has happened along with healthy gains in same-store sales. Management has rightfully focused on improving the store experience and competing more adeptly with the company's larger peers -- CVS Caremark and Walgreen. As a business, Rite Aid looks great and should continue to grow over the long-term with no problem.

The problem here is the market's irrational behavior, as usual. With its huge gain in capital appreciation comes a high hurdle to jump, as Rite Aid is valued at a trailing EV/EBITDA of more than 12 times and a forward P/E of 15.5 times. On the latter, the company is trading on par with CVS and cheaper than Walgreen. Beyond relative valuation, though, the company is priced to grow significantly. The lower-level margins can indeed appreciate quickly if Rite Aid is able to achieve similar margins to its major competitors, but right now that isn't the case. Investors are paying a significant premium for the business that isn't quite warranted, if price is considered paramount.

Rite Aid's business is fine and the market's sell-off over a cyclical event is irrelevant, but investors should not consider the sell-off an opportunity, as the price is still too high.

Top dividend stocks for the next decade
The smartest investors know that dividend stocks simply crush their non-dividend-paying counterparts over the long term. That’s beyond dispute. They also know that a well-constructed dividend portfolio creates wealth steadily, while still allowing you to sleep like a baby. Knowing how valuable such a portfolio might be, our top analysts put together a report on a group of high-yielding stocks that should be in any income investor’s portfolio. To see our free report on these stocks, just click here now.


Read/Post Comments (1) | Recommend This Article (5)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On June 07, 2014, at 9:00 AM, epic125 wrote:

    I have been to two rite aid stores. 50th St and 8th ave and the second on 110st and broadway. The staff is more interested in there social life than helping customers. The lines are very long. If you show them your pissed they have an attitude towards you as if it's your fault. I still own the stock. Hopefully upper management will visit these locations and make the corrections. I doubt that they will.

Add your comment.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2985744, ~/Articles/ArticleHandler.aspx, 12/21/2014 11:24:24 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 2 days ago Sponsored by:
DOW 17,804.80 26.65 0.15%
S&P 500 2,070.65 9.42 0.46%
NASD 4,765.38 16.98 0.36%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

12/19/2014 4:02 PM
RAD $6.77 Down -0.01 -0.15%
Rite Aid Corp CAPS Rating: ***
CVS $95.70 Up +0.18 +0.19%
CVS Health CAPS Rating: ****
WAG $73.23 Down -1.15 -1.55%
Walgreen Company CAPS Rating: ****

Advertisement